WDOM's 8th Annual Research Retreat Day Hosts JAMA Editor-in-Chief

The Weill Department of Medicine’s 8th annual Research Retreat Day attracted an impressive 180 junior faculty, postdoctoral students, graduate students, and research technicians across the Weill Cornell Medicine community on Sept. 12, 2023. All gathered in Belfer Research Building—and on Zoom—to share groundbreaking research representing numerous divisions, including Pulmonary & Critical Care medicine, Hematology & Medical Oncology, Regenerative Medicine, Gastroenterology &...

Drs. Kaner and Glesby Receive NIH Grant to Fund Antibiotic Trial for Patients with HIV and Emphysema

The study is focused on whether doxycycline may slow the progression of emphysema (a type of chronic obstructive pulmonary disease), in people with well-controlled HIV who are current or former smokers.

Dr. Leonard Presents Key Finding at 2022 ASH Annual Meeting: Enhanced Progression-Free Survival in Patients with R/R Indolent non-Hodgkin’s Lymphoma

Dr. John Leonard
Dr. Leonard and colleagues found that rituximab (Rituxan) plus lenalidomide (Revlimid) elicited superior progression-free survival for patients with relapsed/refractory indolent non-Hodgkin’s lymphoma.

Dr. Safford Receives $7.9 Million Grant from NHLBI for the REGARDS-MI Study

Dr. Monika Safford
The new award into REasons for Geographic and Racial Differences in Stroke – Myocardial Infarction (REGARDS-MI) will support both scientific aims and early-stage investigator training, with a focus on structural racism.

In Recognition of National COPD Awareness Month the WDOM Highlights Dr. Martinez and the Division of Pulmonary and Critical Care Medicine

Dr. Fernando Martinez
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the U.S.

Group 2 Innate Lymphoid Cells (ILC2s) Essential in Protecting Barrier Tissues from Parasitic Infections

Dr. David Artis
Dr. Artis and team continue to illuminate the role of ILC2s, a family of white blood cells, with a new discovery published in Nature that has resolved an ongoing controversy.

Dr. Prigerson Wins $7 Million Outstanding Investigator Award from the National Cancer Institute

Dr. Prigerson and her team will be piloting several interventions targeted to end-stage cancer patients and their caregivers to promote better communication and informed decision-making about care options.

Dr. Artis and Colleagues Discover Pain-Sensing Gut Neurons that Protect Against Inflammation

Dr. David Artis
As reported in Cell, these pain-sensing neurons protect against inflammation in the gut as well as the associated tissue damage, apparently by secreting a molecule called substance P.

Dr. Iliev Publishes Key Finding on Fungal Species in Tumors in Cell

Dr. Iliyan Iliev
The breakthrough research holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.

New Automated Screening Tool for Idiopathic Pulmonary Fibrosis (IPF) Utilizes Electronic Medical Records

Dr. Fernando Martinez
IPF, which causes progressive scarring of the lungs due to chronic lung inflammation, is usually fatal because it tends to be diagnosed late in the process when treatments are less effective.

Contact Information

Mailing Address

NewYork-Presbyterian Hospital/
Weill Cornell Medical Center
Weill Department of Medicine
525 East 68th Street, Box 130
New York, NY 10065

Office of the Chair

530 East 70th Street, M-522
New York, NY 10021
Tel: (212) 746-4720
Fax: (212) 746-8793

For information on major gifts, contact:
Emily Anderson
Principal Gifts Officer
(646) 962-7687

Administration Office

1320 York Avenue, HT-621
New York, NY 10021
Tel: (212) 746-4007
Fax: (646) 962-0215

Residency Office

530 East 70th Street, M-507
New York, NY 10021
Tel: (212) 746-4749
Fax: (212) 746-6692